PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引：0
|
作者：
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [31] The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
    Rachiglio, Anna Maria
    Fenizia, Francesca
    Piccirillo, Maria Carmela
    Galetta, Domenico
    Crino, Lucio
    Vincenzi, Bruno
    Barletta, Emiddio
    Pinto, Carmine
    Ferrau, Francesco
    Lambiase, Matilde
    Montanino, Agnese
    Roma, Cristin
    Ludovini, Vienna
    Montagna, Elisabetta Sara
    De Luca, Antonella
    Rocco, Gaetano
    Botti, Gerardo
    Perrone, Francesco
    Morabito, Alessandro
    Normanno, Nicola
    CANCERS, 2019, 11 (03):
  • [32] Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients
    Lewandowska, Marzena Anna
    Jozwicki, Wojciech
    Jochymski, Cezary
    Kowalewski, Janusz
    ONCOLOGY REPORTS, 2013, 30 (03) : 1045 - 1052
  • [33] The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
    Camps, Carlos
    Jantus-Lewintre, Eloisa
    Cabrera, Andrea
    Blasco, Ana
    Sanmartin, Elena
    Gallach, Sandra
    Caballero, Cristina
    del Pozo, Nieves
    Rosell, Rafael
    Guijarro, Ricardo
    Sirera, Rafael
    LUNG CANCER, 2011, 72 (03) : 365 - 369
  • [34] DANISH POPULATION BASED STUDY OF THE PREVALENCE OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN NON SMALL CELL LUNG CANCER (NSCLC) (DAPPER STUDY)
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus R.
    Sorensen, Jens B.
    Mellemgaard, Anders
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S967 - S967
  • [35] The prevalence and prognostic value of KRAS co-mutation subtypes in Chinese advanced non-small cell lung cancer patients
    Cai, Dongjing
    Hu, Chengping
    Li, Li
    Deng, Shichao
    Yang, Jing
    Han Han-Zhang
    Li, Min
    CANCER MEDICINE, 2020, 9 (01): : 84 - 93
  • [36] CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
    Rizzo, Stefania
    Petrella, Francesco
    Buscarino, Valentina
    De Maria, Federica
    Raimondi, Sara
    Barberis, Massimo
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Rampinelli, Cristiano
    De Marinis, Filippo
    Spaggiari, Lorenzo
    Bellomi, Massimo
    EUROPEAN RADIOLOGY, 2016, 26 (01) : 32 - 42
  • [37] KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
    Maus, M. K. H.
    Grimminger, P. P.
    Mack, P. C.
    Astrow, S. H.
    Stephens, C.
    Zeger, G.
    Hsiang, J.
    Brabender, J.
    Friedrich, M.
    Alakus, H.
    Hoelscher, A. H.
    Lara, P.
    Danenberg, K. D.
    Lenz, H. J.
    Gandara, D. R.
    LUNG CANCER, 2014, 83 (02) : 163 - 167
  • [38] Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer
    Akca, Hakan
    Demiray, Aydin
    Yaren, Arzu
    Bir, Ferda
    Koseler, Aylin
    Iwakawa, Reika
    Bagci, Gulseren
    Yokota, Jun
    CANCER GENETICS, 2013, 206 (03) : 73 - 80
  • [39] Determining the appropriate treatment for different EGFR mutations in non-small cell lung cancer patients
    Scodes, Simona
    Cappuzzo, Federico
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (06) : 565 - 576
  • [40] Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Mizoguchi, Kosuke
    Nakamura, Yoichi
    Sano, Kazumi
    Sato, Shuntaro
    Ikegami, Yoji
    Motoshima, Kohei
    Takemoto, Shinnosuke
    Ogawara, Daiki
    Senju, Hiroaki
    Sugasaki, Nanae
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Fukuda, Minoru
    Izumikawa, Koichi
    Mukae, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 377 - 382
12345